HomeNASDAQ:KITE

NASDAQ:KITE

Novartis’ Cutting-Edge Cancer Therapy Gains Critical Recommendation from FDA Advisory Committee

Novartis’ Cutting-Edge Cancer Therapy Gains Critical Recommendation from FDA Advisory Committee

July 13, 2017

Kite Pharma, Inc. Set to Present at Two Investor Conferences in June 2017

Kite Pharma, Inc. Set to Present at Two Investor Conferences in June 2017

June 6, 2017